Fig 1.
Flow diagram of study participant selection.
Table 1.
General characteristics of the study participants with the presence of non-alcoholic fatty liver disease (NAFLD).
Table 2.
Nutrient intake of the participants by the status of nonalcoholic fatty liver disease (NAFLD) status.
Table 3.
Association between dairy product intake and nonalcoholic fatty liver disease (NAFLD).
Table 4.
Association between dairy product intake and components of metabolic syndrome.
Table 5.
Adjusted odds ratio (AOR) and 95% confidence intervals (CIs) for nonalcoholic fatty liver disease (NAFLD) according to components of metabolic syndrome.
Fig 2.
Model of the mediation relationship between dairy product consumption and nonalcoholic fatty liver disease through metabolic syndrome components as mediating variables.
(A) fasting blood glucose. (B) Waist circumference. (C) SBP. (D) DBP. (E) HDL-cholesterol. (F) Triglycerides. The proportion mediated was calculated as the NIE divided by the total effect and was reported as NA when the value exceeded 1. All models were adjusted for age, BMI, education level, occupation, marital status, household income, household type, region, drinking, smoking, total energy intake, and physical activity. NAFLD, nonalcoholic fatty liver disease; NIE, natural indirect effect; NDE, natural direct effect; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein.